<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: The receptor for advanced glycation end products (RAGE) is a cell surface receptor that has been implicated in <z:e sem="disease" ids="C0042373" disease_type="Disease or Syndrome" abbrv="">vascular disease</z:e> and <z:hpo ids='HP_0002180'>neurodegeneration</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Low levels of its secreted isoform, soluble RAGE (sRAGE), have been regarded as a putative risk factor for <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>In addition, administration of sRAGE has been shown to reduce development of cerebral beta-<z:hpo ids='HP_0011034'>amyloidosis</z:hpo> in an <z:hpo ids='HP_0002511'>Alzheimer disease</z:hpo> mouse model </plain></SENT>
<SENT sid="3" pm="."><plain>OBJECTIVE: To investigate the role of sRAGE as a biological marker for <z:hpo ids='HP_0002511'>Alzheimer disease</z:hpo> and vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>DESIGN: Cross-sectional study of 152 patients with a clinical diagnosis of <z:hpo ids='HP_0002511'>Alzheimer disease</z:hpo>, 91 with vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> and 161 control subjects </plain></SENT>
<SENT sid="5" pm="."><plain>MAIN OUTCOME MEASURE: Plasma levels of sRAGE </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: Levels of sRAGE were significantly reduced in the plasma of patients with <z:hpo ids='HP_0002511'>Alzheimer disease</z:hpo> compared with that for those with either vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> (P&lt;.05) or with controls (P&lt;.001) </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: Patients with <z:hpo ids='HP_0002511'>Alzheimer disease</z:hpo> have reduced levels of sRAGE in plasma compared with patients with vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> and controls </plain></SENT>
<SENT sid="8" pm="."><plain>The striking reduction of circulating sRAGE in <z:hpo ids='HP_0002511'>Alzheimer disease</z:hpo> further supports a role for the RAGE axis in this clinical entity and requires further investigation </plain></SENT>
</text></document>